iTEAM - Home Page

CME/CE On-Demand Webcast and Podcast

Up to 1 AMA PRA Category 1 Credit™
1 CNE contact hour

One of the most serious adverse events associated with anticoagulant and thrombolytic therapy is intracerebral hemorrhage (ICH). Often a fatal development in the recent past, today there are effective strategies to counter these life-threatening events. In this program, you'll learn about the latest evidence-based approaches for managing coagulopathic patients with ICH. Presented by an expert in ICH, this activity will explore the incidence, characteristics, and outcomes of ICH associated with oral anticoagulant and thrombolytic therapy; the available treatment options for lowering the international normalized ratio, as well as the latest efficacy data for these agents. In addition, the guidelines for restarting anticoagulation, particularly in patients with atrial fibrillation, will be reviewed. The presentation of clinical study results, including guidance for implementing recent findings and guidelines in clinical practice, will provide stroke team members with best practices they can apply in the treatment of their patients.

This CME/CE activity is part of the ICH Training, Education, Awareness and Management (iTEAM™) Initiative and is designed to improve the care of patients with ICH from hospital admission through discharge.

Participate at your convenience by Web or Podcast!

Programs are available 24 hours a day/7 days a week.

Faculty:

Edward C. Jauch, MD, MS
Assistant Professor
Interim Director of Research
Department of Emergency Medicine
University of Cincinnati College of Medicine
University of Cincinnati Center for Emergency Care
Cincinnati, Ohio

To participate:

Click here to view this program

or

Download .mp3 file

or

Subscribe to our podcast version

Please make sure to download the slide presentation prior to downloading .mp3 or subscribing to the podcast.


	Home Register Faculty Program Description Learning Objectives Intended Audience Credit Information Disclosure Policy Program Materials Help Privacy Policy		Critical Issues in the Management of Intracerebral Hemorrhage: Reversing and Restarting Anticoagulation

			CME/CE On-Demand Webcast and Podcast Up to 1 AMA PRA Category 1 Credit™ 1 CNE contact hour One of the most serious adverse events associated with anticoagulant and thrombolytic therapy is intracerebral hemorrhage (ICH). Often a fatal development in the recent past, today there are effective strategies to counter these life-threatening events. In this program, you'll learn about the latest evidence-based approaches for managing coagulopathic patients with ICH. Presented by an expert in ICH, this activity will explore the incidence, characteristics, and outcomes of ICH associated with oral anticoagulant and thrombolytic therapy; the available treatment options for lowering the international normalized ratio, as well as the latest efficacy data for these agents. In addition, the guidelines for restarting anticoagulation, particularly in patients with atrial fibrillation, will be reviewed. The presentation of clinical study results, including guidance for implementing recent findings and guidelines in clinical practice, will provide stroke team members with best practices they can apply in the treatment of their patients. This CME/CE activity is part of the ICH Training, Education, Awareness and Management (iTEAM™) Initiative and is designed to improve the care of patients with ICH from hospital admission through discharge. Participate at your convenience by Web or Podcast! Programs are available 24 hours a day/7 days a week. Faculty: Edward C. Jauch, MD, MS Assistant Professor Interim Director of Research Department of Emergency Medicine University of Cincinnati College of Medicine University of Cincinnati Center for Emergency Care Cincinnati, Ohio To participate: Click here to view this program or Download .mp3 file or Subscribe to our podcast version Please make sure to download the slide presentation prior to downloading .mp3 or subscribing to the podcast.